This article is more than 5 years old. Information may no longer be current.

Kuros completes financing round, adds new board members

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Kuros Biosurgery AG recently announced it has completed a CHF 15M financing round.

New investors LifeCare Partners and LSP Life Sciences Partners led this round of financing, according to a company release. As part of the financing agreement, Gerhard Ries, PhD, of LifeCare Partners, Jörg Neermann, PhD, of LSP, and Dominik Ellenreider, MBA, will join the Kuros board of directors.

Omega Funds also became a shareholder during this round of financing.

“We are very proud to have a number of high-quality investors join us and we are looking forward to working closely with their experienced investment teams,” Didier Cowling, chief executive officer at Kuros, stated in the release. “At the same time we would like to thank the existing investors for their continued support in this financing round. The funds will allow Kuros to bring our unique sealant products to market and to progress our lead orthobiologics product into the final stage of clinical testing.”